Nephros (NEPH) Invested Capital (2010 - 2022)

Nephros' Invested Capital history runs 8 years deep, the most recent figure standing at $71000.0 for Q4 2022.

• On a quarterly basis, Invested Capital fell 71.37% year-over-year to $71000.0 in Q4 2022; TTM through Sep 2023 was $71000.0, a 91.67% decrease from a year earlier, with the FY2022 full-year figure at $71000.0, down 71.37% from the prior year.
• Invested Capital eased to $71000.0 in Q4 2022 per NEPH's latest filing, from $141000.0 in the prior quarter.
• Across five years, Invested Capital topped out at $991000.0 in Q4 2018 and bottomed at $71000.0 in Q4 2022.
• The 5-year median for Invested Capital is $231000.0 (2020), against an average of $292700.0.
• Across the five-year window, Invested Capital soared 502.45% in 2019 and tumbled 77.19% in 2020, its largest moves.
• Year by year, Invested Capital stood at $991000.0 in 2018, then sank by 69.73% to $300000.0 in 2019, then declined by 23.67% to $229000.0 in 2020, then increased by 8.3% to $248000.0 in 2021, then plunged by 71.37% to $71000.0 in 2022.
• Per Business Quant, the three latest NEPH Invested Capital figures stand at $71000.0 (Q4 2022), $141000.0 (Q3 2022), and $210000.0 (Q2 2022).